USP7 and gastric cancer: In a nutshell, pharmacological and genetic abrogation of USP7 can inhibit the proliferation of MKN45 cells both in vitro and in vivo, which indicates that USP7 can be considered as a promising therapeutic target for the treatment of gastric cancer.